Subscribe to our Newsletters !!

    Minerals

    FDA supports new medication for therapy of adults with chronic kidney infection

    Today, the U.S. Food and Drug Administration accepted Farxiga (dapagliflozin) oral tablets to decrease the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression. Chronic kidney disease occurs when the kidneys are damaged and can’t filter blood

    New gene expression organization can help understand component behind ceaseless stem cell activity in plant

    An inter-university research group has succeeded in constructing the gene expression network behind the vascular development process in plants. They achieved this by doing bioinformatics analysis using the’VISUAL’ tissue culture stage, which generates vascular stem cells from cells. Within this network, they also found a new BES/BZR transcription factor, BEH3, which modulates vascular stem cells.